Cargando…

Comparison of EBRT and I-125 seed brachytherapy concerning outcome in intermediate-risk prostate cancer

PURPOSE: This study’s objective was the comparison of external beam radiotherapy (EBRT) and I‑125 seed brachytherapy regarding clinical outcome and development of side effects. PATIENTS AND METHODS: In all, 462 localized intermediate-risk prostate cancer patients treated between 2000 and 2019 at our...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moll, Matthias, Renner, Andreas, Kirisits, Christian, Paschen, Christopher, Zaharie, Alexandru, Goldner, Gregor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547207/ https://www.ncbi.nlm.nih.gov/pubmed/34351453 http://dx.doi.org/10.1007/s00066-021-01815-z

Ejemplares similares

Treatment of low-risk prostate cancer: a retrospective study with 477 patients comparing external beam radiotherapy and I-125 seeds brachytherapy in terms of biochemical control and late side effects
por: Moll, Matthias, et al.
Publicado: (2020)

Biochemical control after adjuvant radiation therapy for prostate cancer: a unicentric, retrospective analysis
por: Zaharie, Alexandru-Teodor, et al.
Publicado: (2021)

Clinical outcome in metastatic prostate cancer after primary radiotherapy
por: Moll, Matthias, et al.
Publicado: (2022)

Advancements in the radiooncological Treatment of High-risk Prostate Cancer: A Quarter Century of Achievements
por: Moll, Matthias, et al.
Publicado: (2022)

Effects of Gold Fiducial Marker Implantation on Tumor Control and Toxicity in External Beam Radiotherapy of Prostate Cancer
por: Moll, Matthias, et al.
Publicado: (2023)

Bioevaluation of (125)I Ocu-Prosta seeds for application in prostate cancer brachytherapy
por: Mukherjee, Archana, et al.
Publicado: (2014)

Comparative analysis of the prognosis of external beam radiation therapy (EBRT) and EBRT plus brachytherapy for glioblastoma multiforme: a SEER population-based study
por: Yang, Kai, et al.
Publicado: (2022)

Comparative effectiveness of moderate hypofractionation with volumetric modulated arc therapy versus conventional 3D-radiotherapy after radical prostatectomy
por: Moll, Matthias, et al.
Publicado: (2022)

Ten‐step method of high‐dose LDR (125)I brachytherapy for intermediate‐risk prostate cancer
por: Okamoto, Keisei
Publicado: (2021)

Incidence of seed migration to the chest, abdomen, and pelvis after transperineal interstitial prostate brachytherapy with loose (125)I seeds
por: Sugawara, Akitomo, et al.
Publicado: (2011)

Correlations between intraplan and postplan parameters in I-125 permanent prostate brachytherapy using loose seeds or linked seeds
por: Ito, Fumitaka, et al.
Publicado: (2022)

Long-term results with custom-linked iodine-125 seeds and real-time brachytherapy in low- and intermediate-risk prostate cancer
por: Guinot, Jose Luis, et al.
Publicado: (2022)

Experimental study of pelvic perioperative brachytherapy with iodine 125 seeds (I-125) in an animal model
por: Brun, Thomas, et al.
Publicado: (2018)

Prostate-Specific Antigen Bounce after (125)I Brachytherapy Using Stranded Seeds with Intraoperative Optimization for Prostate Cancer
por: Kim, Tae Hyung, et al.
Publicado: (2022)

Late seed migration after prostate brachytherapy with Iod-125 permanent implants
por: Maletzki, Philipp, et al.
Publicado: (2018)

Prostate brachytherapy with iodine-125 seeds: analysis of a single institutional cohort
por: Leite, Elton Trigo Teixeira, et al.
Publicado: (2019)

Analysis of health related quality of life (HRQoL) of patients with clinically localized prostate cancer, one year after treatment with external beam radiotherapy (EBRT) alone versus EBRT and high dose rate brachytherapy (HDRBT)
por: Joseph, Kurian Jones, et al.
Publicado: (2008)

Permanent (125)I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence
por: Mazeron, Renaud, et al.
Publicado: (2012)

I-125 seeds brachytherapy with transcatheter arterial chemoembolization for subcapsular hepatocellular carcinoma
por: Gao, Fu-Lei, et al.
Publicado: (2022)

Erectile function after permanent 125I prostate brachytherapy for localized prostate cancer
por: Njomnang Soh, Patrice, et al.
Publicado: (2013)

Comparison of treatment costs for primary localized prostate cancer in Austria and Vienna: an economic analysis
por: Moll, Matthias, et al.
Publicado: (2023)

Radiofrequency ablation versus (125)I-seed brachytherapy for painful metastases involving the bone
por: Jiao, Dechao, et al.
Publicado: (2016)

Treatment of early stage vaginal cancer with EBRT and MRI-based intracavitary brachytherapy: A retrospective case review
por: Damast, Shari, et al.
Publicado: (2016)

Transperineal prostate brachytherapy, using I-125 seed with or without adjuvant androgen deprivation, in patients with intermediate-risk prostate cancer: study protocol for a phase III, multicenter, randomized, controlled trial
por: Miki, Kenta, et al.
Publicado: (2010)

Seed Density as a New Predictive Index of Seed Migration in Brachytherapy for Prostate Cancer Using Iodine-125 Loose Seed
por: Yamaguchi, Takahiro, et al.
Publicado: (2023)

Iodine-125 seed brachytherapy for early stage prostate cancer: a single-institution review
por: Zuber, Simon, et al.
Publicado: (2015)

Re-implantation after insufficient primary 125-i permanent prostate brachytherapy
por: Putora, Paul Martin, et al.
Publicado: (2013)

Risk factors for rectal bleeding associated with I-125 brachytherapy for prostate cancer
por: Harada, Kosaku, et al.
Publicado: (2012)

Assessment of I-125 seed implant accuracy when using the live-planning technique for low dose rate prostate brachytherapy
por: Moorrees, Joshua, et al.
Publicado: (2012)

Benefits of a dual sagittal crystal transducer for ultrasound imaging during I-125 seed implantation for permanent prostate brachytherapy
por: Kaljouw, Emmie, et al.
Publicado: (2012)

Clinical features of prostate-specific antigen bounce after (125)I brachytherapy for prostate cancer
por: Kubo, Katsumaro, et al.
Publicado: (2018)

(125)I Brachytherapy Seeds Implantation for Inoperable Low-Grade Leiomyosarcoma of Inferior Vena Cava
por: Li, Yuliang, et al.
Publicado: (2013)

New National Air-Kerma-Strength Standards for (125)I and (103)Pd Brachytherapy Seeds
por: Seltzer, Stephen M., et al.
Publicado: (2003)

Combination of Permanent Interstitial (125)I-Seed Brachytherapy and Surgery for the Treatment of Large Hepatocellular Carcinoma
por: Li, Xiaogang, et al.
Publicado: (2017)

(125)I Seed Brachytherapy for Refractory Loco-Regional Recurrence of Non-Anaplastic Thyroid Cancer
por: Yu, Huimin, et al.
Publicado: (2022)

Biliary drainage combined with simultaneous (125)I seed strand brachytherapy for the treatment of hilar cholangiocarcinoma
por: Zhang, Chengzhi, et al.
Publicado: (2023)

The direct prognosis comparison of (125)I low-dose-rate brachytherapy versus laparoscopic radical prostatectomy for patients with intermediate-risk prostate cancer
por: Liang, Zhen, et al.
Publicado: (2023)

Iodine-125 prostate seed brachytherapy in renal transplant recipients: an analysis of oncological outcomes and toxicity profile
por: Beydoun, Nadine, et al.
Publicado: (2014)

Quality of life in patients who underwent (125)I brachytherapy, (125)I brachytherapy combined with three-dimensional conformal radiation therapy, or intensity-modulated radiation therapy, for prostate cancer
por: Nakai, Yasushi, et al.
Publicado: (2019)

Brachytherapy of intra ocular tumors using ‘BARC I-125 Ocu-Prosta seeds’: An Indian experience
por: Khetan, Vikas, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_aq41udc173vad89s6fcjl8f63f